Analyst Undervalued Stocks on the NYS April 2025

April 28, 2025

Analyst Undervalued

Companies on this list are considered undervalued based on the analyst consensus. This means that the average analyst target price is greater than the close price.

New York Stock Exchange

The New York Stock Exchange, located in New York City, is the largest securities exchange in the world by market capitalization of its listed companies.

About the Data

This table includes the close price and analyst target price mean from most recent available data. The fiscal year indicates the year for the analyst target price, as the target may not always be for the current year. The number of estimates indicates the number of analyst targets used to calculate the target price mean.

How do you use this table?

Analysts believe that the companies on this list will see the close price move up to their target price mean by the target year indicated. Companies with a large analyst following or large difference between close price and target price are particularly interesting to investigate further. This becomes a starting point for further analysis to understand why these companies are undervalued. Stocks in this category are generally held for capital appreciation or dividends.

For an in-depth look at the fundamentals and valuation of each company, try the stockcalc platform free for 30 days.

SymbolNameClose PriceTarget Price MeanTarget YearNumber of EstimatesCurrency
BRK.A Berkshire Hathaway Inc 795760.00 836135.00 2025 1 USD
LLY Eli Lilly and Co 884.54 1036.67 2025 3 USD
MA Mastercard Inc 533.48 645.00 2025 6 USD
UNH UnitedHealth Group Inc 418.64 561.00 2025 4 USD
TMO Thermo Fisher Scientific Inc 424.24 596.75 2025 4 USD
TDG TransDigm Group Inc 1378.13 1500.50 2025 2 USD
PH Parker Hannifin Corp 598.02 805.00 2026 1 USD
AZO AutoZone Inc 3609.33 3894.00 2025 2 USD
GWW W.W. Grainger Inc 1013.87 1128.50 2025 2 USD
FICO Fair Isaac Corp 1952.31 2061.33 2025 3 USD
All data provided as at market close April 27, 2025.

Company Details

Berkshire Hathaway Inc

BRK.A:NYS

Close Price

795760.00

Target Price Mean

836135.00

Target Year

2025

Target Price # Estimates

1

Berkshire Hathaway is a holding company with a wide array of subsidiaries engaged in diverse activities. The firm's core business segment is insurance, run primarily through Geico, Berkshire Hathaway Reinsurance Group, and Berkshire Hathaway Primary Group.

Access the stockcalc valuation


Eli Lilly and Co

LLY:NYS

Close Price

884.54

Target Price Mean

1036.67

Target Year

2025

Target Price # Estimates

3

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.

Access the stockcalc valuation


Mastercard Inc

MA:NYS

Close Price

533.48

Target Price Mean

645.00

Target Year

2025

Target Price # Estimates

6

Mastercard is the second-largest payment processor in the world, having processed close to $10 trillion in volume during 2024. Mastercard operates in over 200 countries and processes transactions in over 150 currencies.

Access the stockcalc valuation


UnitedHealth Group Inc

UNH:NYS

Close Price

418.64

Target Price Mean

561.00

Target Year

2025

Target Price # Estimates

4

UnitedHealth Group is one of the largest private health insurers and provides medical benefits to about 51 million members globally, including 1 million outside the US as of December 2024. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in medical insurance.

Access the stockcalc valuation


Access our valuation for these companies and 9,000+ more

Try the stockcalc platform free for 30 days

Sign Up

Thermo Fisher Scientific Inc

TMO:NYS

Close Price

424.24

Target Price Mean

596.75

Target Year

2025

Target Price # Estimates

4

Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year end-2024 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (54%).

Access the stockcalc valuation


TransDigm Group Inc

TDG:NYS

Close Price

1378.13

Target Price Mean

1500.50

Target Year

2025

Target Price # Estimates

2

TransDigm manufactures and services a diverse set of specialized parts for commercial and military aircraft. The firm organizes itself in three segments: power and control, airframes, and a small non-aviation segment, which serves mostly off-road vehicles and mining equipment. It operates as an acquisitive holding company that focuses its portfolio on firms that make proprietary aerospace products with substantial aftermarket demand.

Access the stockcalc valuation


Parker Hannifin Corp

PH:NYS

Close Price

598.02

Target Price Mean

805.00

Target Year

2026

Target Price # Estimates

1

Parker Hannifin started out in 1917 as Parker Appliance, selling pneumatic brakes. Through the acquisition of branded components, the firm has expanded into aerospace engines, agricultural and construction machinery, freight and passenger vehicles, and industrial automation equipment. Within these larger systems, Parker sells a wide array of small, critical pieces such as hydraulic, electromechanical, climate control, and filtration components.

Access the stockcalc valuation


AutoZone Inc

AZO:NYS

Close Price

3609.33

Target Price Mean

3894.00

Target Year

2025

Target Price # Estimates

2

AutoZone operates as a leading retailer of aftermarket automotive parts in the United States. The firm operates more than 6,400 stores domestically, serving both the do-it-yourself and commercial (do-it-for-me) end markets. Through its vast store footprint and distribution network, AutoZone manages a wide array of stock-keeping units applicable to numerous vehicle makes and models, providing its consumers with ample product availability.

Access the stockcalc valuation


W.W. Grainger Inc

GWW:NYS

Close Price

1013.87

Target Price Mean

1128.50

Target Year

2025

Target Price # Estimates

2

W.W. Grainger distributes maintenance, repair, and operations products that are sourced from over 5,000 suppliers. The company serves more than 4.5 million customers through its online and electronic purchasing platforms, vending machines, catalog distribution, and network of over 300 global branches.

Access the stockcalc valuation


Fair Isaac Corp

FICO:NYS

Close Price

1952.31

Target Price Mean

2061.33

Target Year

2025

Target Price # Estimates

3

Founded in 1956, Fair Isaac Corporation is a leading applied analytics company. Fair Isaac is primarily known for its FICO credit scores, which is a widely used industry benchmark to determine the creditworthiness of an individual consumer. The firm's credit scores business accounts for most of the firm's profits and consists of business-to-business and business-to-consumer services.

Access the stockcalc valuation


Access thousands of valuation reports

Try the stockcalc platform for 30 days for unlimited access to our valuation reports

Sign Up
Berkshire Hathaway and Eli Lilly are among the most undervalued NYS stocks this month. See the most undervalued companies on the blog: https://www.stockcalc.com/Blog/analyst-undervalued-stocks-nys-april-2025
Berkshire Hathaway $BRK.A and Eli Lilly $LLY on the #NYS among the most undervalued this month. See the full list of undervalued companies: https://www.stockcalc.com/Blog/analyst-undervalued-stocks-nys-april-2025
Berkshire Hathaway and Eli Lilly are among the most undervalued NYS stocks this month. See the most undervalued companies on the blog: https://www.stockcalc.com/Blog/analyst-undervalued-stocks-nys-april-2025

Copyright © 2016- Patchell Brook Equity Analytics Inc. All rights reserved.

Risk Disclosure: Equities trading and trading of all markets, exchanges and instruments contains substantial risk and is not for every investor. An investor could potentially lose all or more than the initial investment. Risk capital is money that can be lost without jeopardizing ones’ financial security or life style. Only risk capital should be used for trading and only those with sufficient risk capital should consider trading. Past performance is not necessarily indicative of future results. View full risk information here.